Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity

NCT02241109 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.

NCT NCT02241109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02241109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2014
Completion date
February 28, 2017
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve sclerosis, aortic valve stenosis, stenosis progression, valvular heart disease